Thank you for submitting your manuscript for consideration by the EMBO Journal. It has now been evaluated by three referees and I enclose their reports below. While the referees find that the current study is potentially interesting they unfortunately find that it is too preliminary for publication in the EMBO Journal.
I hope that you understand if I do not go though each individual criticism in this letter, but all the referees raise a number of important concerns and request a large number of controls, which are currently lacking. One major concern of both referee #2 and #3 is that there no data demonstrating a direct role of the alphaCP protein in regulating assembly of polyadenylation factors and cleavage/polyadenylation efficiency. Importantly, it is clear that these experiments together with large number of requested controls required to convincingly support the dual role of alphaCP in regulating mRNA stability and 3'end processing, would take a significant amount of time and longer than the three months that the EMBO Journal allows for a period of revision. Therefore, given the amount of additional experimental work required and that the referees find that the current manuscript is not suitable for publication in this journal the absence of these additional experiments and the fact that we can only afford to continue handling of papers that receive enthusiastic support from at least a majority of referees upon initial review, I am afraid, I see little choice but to come to the conclusion that we cannot offer to publish this study.
However, as I mentioned the referees find the potential dual role of alphaCP to be potentially interesting, and they do suggest that if the study was to be extended in this way in the future it could potentially be suitable for publication in the EMBO Journal. Therefore, if you are able to extend the study experimentally as suggested we would be willing to look at the manuscript once more. I would like to stress that if you were to follow this option I would attempt to get the same referees to look at the study once more, however depending on their availability this manuscript may be viewed as a new submission rather than a revised manuscript; this could potentially entail the selection of new referee(s) and may involve a new round of peer review. If you decide to thoroughly expand the manuscript and submit an improved version to the EMBO Journal, please make sure to mention the initial manuscript number to allow efficient handling. At this stage of analysis, though, I am sorry to have to disappoint you.
Thank you in any case for the opportunity to consider your manuscript. I am sorry we cannot be more positive on this occasion, but we hope nevertheless that you will find our referees' comments helpful. We also hope that this negative decision does not prevent you from considering our journal for publication of your future studies.
Yours sincerely, Editor
The EMBO Journal
------------------------------------------------REFEREE COMMENTS
Referee #1:
This paper describes how the alphaCP protein, which has previously been shown to bind a C-rich motif in the 3'UTR of the human alpha-globin gene and have an important role in stability of cytoplasmic alphaglobin mRNA, also regulates the production of mRNA in the nucleus by enhancing pre-mRNA 3' end processing. This is a very nice demonstration of the functional significance of a new USE sequence. It is also very interesting in that it describes a protein which has multiple functions in alpha-globin mRNA metabolism in both the nucleus and the cytoplasm.
Various lines of evidence for the role of alphaCP protein in 3' end processing are presented I have listed these below alongside criticisms and suggestions for improvements. Figure 1 shows how efficient mRNA production is dependent on the integrity of the alphaCP protein C rich binding motif in the alpha globin 3' UTR. It is then shown how disruption of the binding motif leads to a significant increase in the level of alpha globin transcripts that are not cleaved at the poly(A) cleavage site. There is a problem with the labeling of Fig 1D. It might be more accurate and easier to understand if the labels beside the data panels referred to 'uncleaved' transcripts in the upper panel and 'total spliced' transcripts in the lower panel. It would be of interest to show the abundance of any unspliced transcripts resulting from PCR amplification with primers a + b. According to models of the interdependence of RNA processing events unspliced transcripts might be more abundant when poly(A) site cleavage is inhibited by removal of the C rich sequence in the 3'UTR.
In Figure 2 the independence of the alphaCP effect on 3' end processing from another alphaCP binding site in intron 1 of the alphaCP mRNA and the cell type specificity of the 3' end processing effect are shown. This Figure could possibly be included in Figure 1 .
In Figure 3 a poly(A) site competition assay is used to provide further evidence for the hypothesis that cleavage efficiency is enhanced by alphaCP protein binding to the alpha globin 3' UTR. Again the labeling of the data panels is rather confusing. In this case it might be better to label the upper band referring to its processing at the bGH poly(A) site. An additional useful control would be to confirm that the band labeled 'unprocessed' actually represents transcripts that are cleaved and polyadenylated at the bGH poly(A) site. This could be done by RT-PCR using oligo dT primer.
In Figure 4 UX X linking showing the sequence specificity of alphaCP binding and an in vitro cleavage analysis confirming the in vivo data is shown.
In Figure 5 an in vitro assay measuring polyadenylation of pre cleaved alpha globin substrate in nuclear extract shows how alphaCP protein, binding to the alpha globin 3' UTR, is required for efficient polyadenylation.
In Figure 6 a co-IP experiment shows interactions between alphaCP protein and core components of the RNA 3' processing complex.
In Figure 7 to address the question of the possible recruitment of alphaCP to the alpha globin gene locus the authors have conducted ChIP on K562 cells using alphaCP antibody. The result of this experiment is not very informative. It indicates that alphaCP is not recruited at the alpha globin promoter and is more abundant at the 3' end of the gene as would be expected because it is involved in 3' end processing.
Referee #2:
In this manuscript, Liebhaber and colleagues provide evidence that a regulatory sequence present in the 3' UTR of the human alpha-globin transcript and the associated proteins confer not only stability of the corresponding mRNA as was previously known, but also mRNA 3' end processing. The main message that the auhors want to convey is that a 3'UTR binding protein may affect the fate of a target mRNA through distinct mechanisms in the nucleus and the cytoplasm.
Overall, this is an interesting story even if the authors fail to mention related observations including some reported in the EMBO Journal (e.g., the implication of the yeast Cth2 protein both in cytoplasmic mRNA destabilization and nuclear polyadenylation). Yet, the data presented are not fully convincing and would benefit to be strengthened before a possible publication:
-The data shown in Figure 1D to suggest that the 3' UTR sequence of the globin mRNA promote is processing is not totally convincing. Indeed, the time point showing a difference is at 2 hours after transcriptional shut-off. Can the authors present data supporting their interpretation? Indeed, it is unlikely that transcription and processing of the reporter takes that long. An alternative possibility is that transcription of the mutant reporter is not repressed as well as WT. Or, do the authors suggest that there is a pool of unprocessed stable RNA in the mutant. In such case, could it be possible that the 3'UTR mutation stabilize those aberrant molecules? -The in vitro cleavage and polyadenylation data are of low quality and not totally convincing, particularly Figure 4C . Could the authors provide higher quality data? -The model suggested by the authors is somewhat confusing: If alpha-CP recruits/stabilize CPSF, how is it able to stimulate both cleavage and polyadenylation? -Have the authors tried to tether alpha-CP to see if this affects the termination/polyadenylation of a reporter?
Other points: Figure 1B and throughout the manuscript: The use of QRT-PCR rather than semi-quantitative PCR would have been more convincing. Figure 3B : It is already worrisome that the authors do not use QRT-PCR to assay RNA levels but only semi-quantitative PCR, to avoid comparing different gels. The different samples should be migrated and quantified in parallel.
Discussion is rather lengthy.
Referee #3:
This manuscript reports the potentially very interesting finding that PCBP/alpha-CP protein is a positive regulator of 3' end processing via interactions with the complex of factors that interacts with the core upstream AAUAAA polyadenylation element. However several aspects of the study appear to be somewhat preliminary in nature and I have outlined below a number of controls and additional experiments that I believe should be performed in order to provide more complete and convincing support for the conclusions of the study:
1. Fig. 4C : Given the level of background degradation of the RNA substrate in these assays, the authors need to validate that the bands they point out are truly cleavage products. Showing a zero timepoint and a more detailed time course of cleavage (only a 90 min incubation point is currently shown) should help address this concern.
2. Fig. 4B : The cross linked & immunoprecipitated alpha CP protein migrates to my eye slower than the majority of the cross linked band that the arrow is pointing to in these gels. Thus the immunoprecipitation assays should be performed for all variant RNAs, not just the wt transcript to allow for a clear analysis of CP cross linking efficiency. Also, since not all RNA-protein interactions can be efficiently detected by UV cross linking, technically alpha CP could still be bound to the '#3' variant. Thus I would suggest that the authors try co-immunoprecipitating the RNA with alpha CP antisera in this experiment to get a clearer picture of 'all' types of RNA protein interactions that may be occurring.
3. Since alpha-CP is an RNA stability factor, can the author's rule out in Figs 4 and 5 that the cleaved/polyadenylated products are simply less stable in the nuclear extracts when the RNA can't bind alpha-CP as opposed to being produced less efficiently? Perhaps careful quantification of processing efficiency could address this point. 4. Fig. 5 : It is very surprising that the polyadenylation observed in these reactions is AAUAAAindependent and makes me wonder about the biological relevance of the data. The methods section for this experiment is rather sparse -was manganese perhaps added to the reaction to make the PAP enzyme sequence-independent? 5. Fig. 5 : The data should be presented in a quantified fashion. Was polyadenylation efficiency (e.g. % processed) increased or was the same amount of RNA processed but the length of the poly(A) tail simply shorter in these studies? 6. 7. Fig. 6 : Since RNase A does not cut the poly(A) tail, the authors may wish to ensure that the co-ippt between these PA factors and alpha-CP is indeed RNA independent by treatment with a broad specificity RNAse such as RNAse ONE.
8. Fig. 6 : Only a select subset of polyadenylation factors is assayed for interactions with alpha CP. Thus the experiment is a bit incomplete. Since alpha-CP appears to substitute for the AAUAAA element in Fig. 4 , did PAP also co-ippt with alpha CP? 9. Fig. 6 : A great way to augment these co-ippt data and directly demonstrate a role for alpha-CP in assembly of PA factors on an RNA substrate would be to directly show recruitment of these factors via a cross-linking /Ippt (or RNA -co-IPPT) study on RNA substrates +/-the alphaCP binding sites. 10. Fig. 7 : Since all of the in vitro data use HeLa nuclear extracts, the authors should show the negative ChiP data for HeLa cells.
11
. A key piece of data that is missing from the study is a direct demonstration for the alpha-CP protein in cleavage/polyadenylation efficiency (rather than just its binding site). These data could be generated by analysis of siRNA knockdown cells or immunodepletion of alphaCP from nuclear extracts.
Resubmission 24 February 2011
We are now submitting a substantially revised version of our manuscript that responds to each of the reviewer's comments and suggestions. These changes encompass new data, revised figures, revised text, and expanded supplemental data. Our responses to each point in the critique are listed in a point-by-point format.
Editors comment: "One major concern of both referee #2 and #3 is that there no data demonstrating a direct role of the alphaCP protein in regulating assembly of polyadenylation factors and cleavage/polyadenylation efficiency."
Response:
In the revised manuscript we highlight several sets of data that support the conclusion that αCP is directly involved in the 3' processing studies. These include -enhancement of in vitro processing by addition of recombinant αCP, -concordant mapping of αCP binding with enhancement of in vitro processing activity (cleavage and polyadenylation), -identification of αCP at the 3' terminus of the hα-globin chromatin locus by ChIP, and -in vivo association of αCP with critical 3' processing factors. We also make an effort to highlight the limits of our conclusions regarding the respective roles of the cisacting element (C-rich motif) and the trans-acting factor (αCP) in enhancing 3' processing. Irrespective of this distinction, we would emphasize that our report, comprising both in vivo and in vitro data, demonstrate that the C-rich domain within the 3' UTR of the hα-globin mRNA, most likely in conjunction with the bound αCP protein (see above), constitutes a novel determinant of both 3' cleavage and subsequent polyadenylation of a mammalian gene transcript.
Referee #1 We appreciate the reviewer's supportive introductory comment that…This is a very nice demonstration of the functional significance of a new USE sequence. It is also very interesting in that it describes a protein which has multiple functions in alpha-globin mRNA metabolism in both the nucleus and the cytoplasm.

Comment: There is a problem with the labeling of Fig 1D. It might be more accurate and easier to understand if the labels beside the data panels referred to 'uncleaved' transcripts in the upper panel and 'total spliced' transcripts in the lower panel.
Response:
We agree with this suggestion and have altered the labeling of the figure accordingly.
Comment: It would be of interest to show the abundance of any unspliced transcripts resulting from PCR amplification with primers a + b. According to models of the interdependence of RNA processing events unspliced transcripts might be more abundant when poly(A) site cleavage is inhibited by removal of the C rich sequence in the 3'UTR.
Response:
We note in the revised text that we have previously demonstrated (Ji et al, 2007 MCB) that removal of αCP-binding site from the hα-globin 3' UTR (α-Neut mutation) significantly increases the levels of unspliced transcripts. We further show by selective mutations in the transcript and by in vitro assays that the impact of the 3' UTR C-rich determinant on splicing and 3' processing are independent effects. 
While these two figures could be combined (and we would be willing to do so), we are concerned that a combined figure would become too complex and for reasons of clarity we would prefer if they remain separate.
Comment: In Figure 3 a poly(A) site competition assay is used to provide further evidence for the hypothesis that cleavage efficiency is enhanced by alphaCP protein binding to the alphaglobin 3' UTR. Again the labeling of the data panels is rather confusing. In this case it might be better to label the upper band referring to its processing at the bGH poly(A) site.
Response:
While we appreciated the suggestion of the reviewer, we would point out that this assay does not specifically measure processing at the bGH site. Instead, we are measuring the inhibition of normal processing when placed in cis to the strong bGH polyA site. Thus to maintain maximal accuracy we have chosen to use the uniform labeling scheme referring to cleavage of the hα-globin transcript as recommended by this reviewer for Figs. 1 and 2.
Comment: An additional useful control would be to confirm that the band labeled 'unprocessed' actually represents transcripts that are cleaved and polyadenylated at the bGH poly(A) site. This could be done by RT-PCR using oligo dT primer.
Response:
To address this point we have added additional data summarized in Supp Fig. 1 . These data support the experimental assumption that the competition effect reflects the strong 3' processing activity of the bGH polyA signal.
Comment: In Figure 7 to address the question of the possible recruitment of alphaCP to the alphaglobin gene locus the authors have conducted ChIP on K562 cells using alphaCP antibody. The result of this experiment is not very informative. It indicates that alphaCP is not recruited at the alphaglobin promoter and is more abundant at the 3' end of the gene as would be expected because it is involved in 3' end processing.
Response:
We have modified the text dealing with this experiment to make the rationale of the study more evident. We emphasize that the ChIP study was designed to differentiate between two models extant in the field: 3' processing factors load on PolII (CTD) at the point of initiation of transcription elongation verses a model in which processing factors are directly recruited to the mRNA as Pol II transcribes through the 3' terminus and generates the target transcript. Our ChIP data support the second of these two models by revealing that αCP is preferentially loaded at a late stage of transcription. We also note that the CHIP analysis also supports the conclusion that a 3'UTR RNP complex containing αCP is involved in 3' end processing of hα-globin transcript.
Referee #2
Comment: Overall, this is an interesting story even if the authors fail to mention related observations including some reported in the EMBO Journal (e.g., the implication of the yeast Cth2 protein both in cytoplasmic mRNA destabilization and nuclear polyadenylation).
Response:
We thank the reviewer for his/her positive support and for bringing to our attention the noted publication which is now included in the report. Figure 1D to We appreciate the reviewer's concern, but would ask that he/she re-consider this data and its implications. The data reveal that the level of unprocessed transcript is maximal at 0 hours (i.e., at the end of the transcriptional pulse period) with marked decrease in the level of unprocessed transcript at 2 hours into the chase period. This pattern is what would be expected with the Tet-off approach and is what we routinely observe with this system. Recall that at 0 hours new transcripts are still being synthesized and the accentuation of this level in the case of the αNeut gene is fully consistent with inefficiency in posttranscriptional processing. The detection of residual unprocessed transcripts at 2 hours further supports the documented inefficiency in 3' processing (as further defined by our in vitro studies). The important point is that the level is markedly higher in the transcript lacking the C-rich αCP binding site, consistent with a defect in 3' processing (as further supported by the subsequent in vitro assays).
Comment: The data shown in
Comment: An alternative possibility is that transcription of the mutant reporter is not repressed as well as WT Response:
We note that all the transgenes are under the control of the identical Tet-controlled promoter cassette. While a formal possibility, it would seem unlikely that the difference in 3' UTR sequence would modulate the rate of transcription initiation in our experimental setting. The various lines of investigation in our study support the conclusion that the accentuation of unprocessed transcripts secondary to the deletion of C-rich region represents a defect in 3' processing. We observe very little precursor in the case of the efficiently processed αWT transcript. The residual levels of unprocessed αNeut transcript that we observe at 2 hours into the chase are subsequently cleared. Our previous in vitro studies (Ji et al., 2007) have demonstrated equivalent stability of the αWT and αNeut transcripts. While we acknowledge that in vitro studies have their limitations, we note that it is quite difficult to study the intrinsic stability of unprocessed nuclear transcripts in vivo, and it is for this reason that we complement our in vivo studies with a full set of in vitro (cleavage and polyadenylation) analyses.
Comment
Comment:
The in vitro cleavage and polyadenylation data are of low quality and not totally convincing, particularly Figure 4C . Could the authors provide higher quality data? Response:
We have carried out this study multiple times, with a consistent result that is best represented in the presented figure. While there are background bands on the gel, we find that given the conditions of this assay, incubating the transcript in nuclear extract, this background is unavoidable (at least in our hands). What is important to note is that the background bands are equivalent in all lanes and the only bands that differ from one lane to another correspond to the 5' and 3' cleavage products. These bands are of the correct size as defined by the αWT vs αNeut study and are markedly diminished or absent in the mut 3 and PA mut lanes. The authenticity of these bands are further supported by the addition of a time course control for cleavage assay (Fig. 4 C) which shows that they are absent in the input and are generated in a time dependent manner in the in vitro reaction.
Comment: The model suggested by the authors is somewhat confusing: If alpha-CP recruits/stabilize CPSF, how is it able to stimulate both cleavage and polyadenylation
Response:
We propose in our model that the C-rich region of the 3'UTR region acts as a co-activator for the recruitment of the cleavage complex to the pre-RNA at the AAUAAA. Upon deletion of the αCP complex the activity of the isolated AAUAAA appears to be insufficient for the assembly of the cleavage complex to the hα-globin transcript. Our in vitro assays demonstrate that the cleavage reaction is dependent on the actions of both the C-rich region and the AAUAAA. The model further proposes that αCP is retained on transcript post-cleavage (supported by our prior demonstration that αCP remains bound to the 3' UTR of the fully processed hα-globin mRNA (Ji,MCB, 2003) ) where it can then recruit PAP, resulting in the observed stimulation of the polyA reaction. The positive roles for the αCP-binding site in each of the two steps in the 3' processing pathway is supported by the corresponding in vitro cleavage and polyadenyltion reaction assays. We have tried to make this model more apparent in the revised Discussion.
Comment: Have the authors tried to tether alpha-CP to see if this affects the termination/polyadenylation of a reporter?
Response:
This has not been done. We have found that such studies, while of potential utility, can also be problematic in their interpretation. We have, however, carried out a supplementation assay with recombinant αCP that supports the proposed model. These data are included in Fig 5. Comment: Figure 1B and throughout the manuscript: The use of QRT-PCR rather than semi-quantitative PCR would have been more convincing.
While qPCR is an option, the sizes of most of our PCR products are beyond the size limits for a qPCR. We have demonstrated that our RT/PCR assays are in linear range. As an example, one of these controls has been included in Supp Fig. 1 .
Comment: Figure 3B: …. avoid comparing different gels. The different samples should be migrated and quantified in parallel.
Response: All data in the figure were run on the same gel in the revised figure. This is now noted in the text.
Comment: Discussion is rather lengthy.
Response: We have shortented the Discussion to increase clarity and reduce potential redundancies.
Referee #3 Comment: Fig. 4C: Given the level of background degradation of the RNA substrate in these assays, the authors need to validate that the bands they point out are truly cleavage products. Showing a zero timepoint and a more detailed time course of cleavage (only a 90 min incubation point is currently shown) should help address this concern.
Response:
In response to the reviewer's suggestion we have added a time course study (Fig. 4C, left panel) . This study confirms that the two bands designated as the cleavage products are generated by the reaction (ie., not present in input) and are time-dependent in their appearance.
Comment: Fig. 4B: The cross linked & immunoprecipitated alpha CP protein migrates to my eye slower than the majority of the cross linked band that the arrow is pointing to in these gels
Response:
This impression is due to a slight 'smile' in the gel in the left panel. To rectify this situation we now present the full intact gels (Fig. 4B) which clearly show the relative positioning of the αCP complex.
Comment: Thus the immunoprecipitation assays should be performed for all variant RNAs, not just the wt transcript to allow for a clear analysis of CP cross linking efficiency. Also, since not all RNA-protein interactions can be efficiently detected by UV cross linking, technically alpha CP could still be bound to the '#3' variant. Thus I would suggest that the authors try co-immuno-precipitating the RNA with alpha CP antisera in this experiment to get a clearer picture of 'all' types of RNA protein interactions that may be occurring.
Response:
In response, we include a second, technically independent RNA-protein interaction assay: RNA-EMSA. These data are fully consistent with the cross-linking studies and confirm that mutant #3, alone or in combination with other mutations, disrupts formation αCP complex (new Supp Fig. 2) .
Comment: Since alpha-CP is an RNA stability factor, can the author's rule out in Figs 4 and 5 that the cleaved/polyadenylated products are simply less stable in the nuclear extracts when the RNA can't bind alpha-CP as opposed to being produced less efficiently? Perhaps careful quantification of processing efficiency could address this point.
Response:
We note in the revised text that in a prior publication (Ji et al., 2007 MCB) we demonstrated that the RNAs with or without the 3'UTR αCP binding sites has similar stability when incubated in nuclear extract in vitro reaction systems. This suggests to us that the data do not reflect a significant component of differential RNA stability of the in vitro cleavage/polyA products. Furthermore, we have now calculated the ratio of processed signal + remaining substrate to the input substrate for the cleavage and the polyadenylation reactions of the WT and Neut transcripts and determined in both cases that mutation of the C-rich region (αNeut transcript) does not decrease the overall signal of the RNA species. This is noted in the revised results. Finally, we note that the 3' cleavage product is identical for the αWT and the αNeut transcripts, obviating any possible difference in their stabilities.
Comment: Fig. 5: It is very surprising that the polyadenylation observed in these reactions is AAUAAAindependent and makes me wonder about the biological relevance of the data. The methods section for this experiment is rather sparse -was manganese perhaps added to the reaction to make the PAP enzyme sequence-independent?
Response:
To address this point we have added details to the revised Methods. Specifically, manganese was not included in the reaction. We were indeed surprised to observe that polyadenylation was fully maintained by the αCP complex in the absence of a functional AAUAAA. This set of data, which was robust and reproducible, highlights the important role of C-rich motif in the polyA reaction for the hα-globin transcript. This result is supported by the observation that there is a decrease in the strength of polyA tail upon mutation of the C-rich region (mut #3) and a complete loss of activity when this mutation is linked to loss of the AAUAAA function. Thus the C-rich region plays an essential and non-redundant role in the polyA reaction in this setting. The finding that the C-rich element can efficiently compensate for the loss of the AAUAAA in the in vitro polyA addition reaction is a novel component of our report. Fig. 5 : The data should be presented in a quantified fashion. Was polyadenylation efficiency (e.g. % processed) increased or was the same amount of RNA processed but the length of the poly(A) tail simply shorter in these studies?
Comment:
Response:
The observation from the gel analyses is that the length of the polyA tails does not appear to show a significant difference while the intensity of the signal is the major variable. This observation is substantiated by the ratio of polyadenylated RNA over input substrate. These calculations (added to the revised figure) reveal that the major impact of the C-rich region is an increase in the percent of the RNA processed. We would thus conclude that the major impact was on overall efficiency of substrate utilization rather than length of the individual tails.
Comment: Fig. 5: Is the 90 min time point shown in the linear range of the reaction? It would be more convincing to show a time course of polyadenylation rather than a single time point.
Response:
In response to this comment, we have added a time course control study to the revised manuscript Fig. 5C ). These data support our conclusions and model. Fig. 6 : Since RNase A does not cut the poly(A) tail, the authors may wish to ensure that the co-ippt between these PA factors and alpha-CP is indeed RNA independent by treatment with a broad specificity RNAse such as RNAse ONE.
Comment:
Response:
In response to this comment we have carried out studies with RNaseOne. We observe that the treatment of the extracts with RNaseOne gives results that are fully in agreement with those generated with RNaseA ( Supp Fig. 3) . Fig. 4 , did PAP also co-ippt with alpha CP? Response:
Comment: Fig. 6: Only a select subset of polyadenylation factors is assayed for interactions with alpha CP. Thus the experiment is a bit incomplete. Since alpha-CP appears to substitute for the AAUAAA element in
In response to this comment we have added to the revised manuscript (Fig. 6 ) a co-IP that demonstrates RNAse-resistant association of αCP with the nuclear poly(A) polymerase, PAPa. Fig. 6 
Comment:
Response:
In response to this suggestion we tried to carry out these study. Unfortunately the results were not definitive one way or the other due to the low level of these factors. Our new data demonstrating that αCP interacts with major nuclear polymerase (PAPa) and that αCP enhances poly(A) addition supports the model that αCP recruits 3' end processing machinery to hα-globin gene to enhance its 3' end processing.
Comment: Fig. 7: Since all of the in vitro data use HeLa nuclear extracts, the authors should show the negative ChiP data for HeLa cells.
Response:
In response to this suggestion we have carried out the ChIP study on HeLa cells. As expected, the results were negative -this study is included in the revised manuscript (Fig. 7) .
Comment: A key piece of data that is missing from the study is a direct demonstration for the alpha-CP protein in cleavage/polyadenylation efficiency (rather than just its binding site). These data could be generated by analysis of siRNA knockdown cells or immunodepletion of alphaCP from nuclear extracts.
Response:
Please see response to Editor's comment.
2nd Editorial Decision 23 March 2011
Thank you for submitting your manuscript for consideration by the EMBO Journal. It has now been seen by two of the original referees and I enclose their comments below. As you will the the referees find that the manuscript has been significantly strengthened, however, there are a number of important concerns that still need to be addressed, particularly those raised by referee #2. Should you be able to address these remaining concerns we would be happy to consider a revised version of the manuscript.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely,
Editor
Referee #1 (Remarks to the Author):
Overall I think that the authors have done a terrific job in addressing the vast majority of the concerns raised in the previous reviews. While I think the conclusions of the manuscript are convincing as presented, I do however still have two comments that I think would strengthen the study if the authors chose to address them here.
1. One of the points raised in the previous critiques concerned the biological relevance of the AAUAAAindependent polyadenylation of this RNA that is observed in vitro. While the authors nicely established the reproducibility of this observation in extracts, they did not address it in cells. Hence the biological relevance question of the in vitro observation remains unanswered in my opinion. If the authors choose, I think that it would be informative for them to test the functionality of the AAUAAA mutant of the alpha globin poly(A) signal in transfection assays in living cells. The prediction from the extract-derived data would be that it would still largely be processed/polyadenylated in a robust fashion due to the presence of an intact C-rich element.
2. Re the last point of Reviewer 3#: I'm curious (and I bet a good number of the EMBO readership will be as well): can you knock down alpha CP and see effects on polyadenylation in vivo -or are there technical limitations (e.g. functional redundancy of closely related proteins, etc) that preclude this apparently straightforward experiment from being performed in an interpretable fashion?
Referee #2 (Remarks to the Author):
The authors have provided a revised version of their manuscript including answers to the comments made by the referee's. If the corrections clearly improved the manuscript, the answers to two items do not convince me:
-I had indicated that the time course experiment shown in the original Figure 1D was not convincing because the difference was seen 2 hours after transcriptional shut-off, a delay that made me wonder whether this was really related to RNA processing or if some other events could be implicated. I had suggested alternative interpretations. The authors' answers are disappointing, as they do not provide further support for their interpretation. While I agree that their model is compatible with their data, alternative interpretations remain possible as well. In fact other studies indicate that by two hours after transcriptional shut-off of a Tet promoter, all beta-globing mRNA is being deadenylated in the cytoplasm (e.g., Couttet and Grange, NAR, 2004) . It is difficult to reconcile these different kinetic and I'm not convinced that the in vivo evidence to support a defect in processing is sufficiently strong.
-I had commented that most quantification assays were performed by RT-PCR and recommended that the authors use rather quantitative RT-PCR. The authors argue that given the size of the amplified fragments, those cannot be used in QRT-PCR assays. While this is correct, they could have designed shorter amplicons to validate their conclusions. Going back to Figure 1D (see above), it is indeed worrisome that the critical signal supporting a difference of processing in vivo is observed comparing different gels, possibly exposed for different times, using PCR products of different sequence! This situation is far from being convincing and probably do not meet the technical quality standards required for publication.
Given these problems remaining, I believe that the manuscript still needs to be improved before an hypothetical publication. Thank you for the prompt and helpful response to our revised manuscript. We appreciate your suggestions and the comments of the two reviewers and we have summarized our responses in a point-by-point format, as follows.
Referee #1 (Remarks to the Author):
" We appreciate this comment by the reviewer. In response we wish to point out that our work demonstrates that the polyadenylation reaction can be driven by the C-rich region independent of the AAUAAA (at least in vitro). However, this is not the case for the preceding cleavage reaction. For example, the data shown in Fig. 4 , indicates that the 3' cleavage of a-globin 3'UTR is dependent on the presence of both the C-rich region and AAUAAA. We find that disruption of either motif severely inhibits the cleavage reaction. Thus, while it is true that the C-rich region can fully compensate in vitro for the loss of the AAUAAA at the second step of 3' end processing (polyadenylation; see Fig. 5 ), this second step in 3' modification cannot occur in the absence of the preceding cleavage step. These findings would predict that mutation of the AAUAAA would effectively block 3' processing in vivo. Our in vivo transfection assays (data not shown) are fully consistent with this prediction and with the literature: 3' end processing of the α-globin transcript with an inactivated AAUAAA determinant is severely affected in its expression in that less than 20% of the AAUAAA-mutant transcripts are properly cleaved and polyadenylated. We do not include this data regarding the in vivo impact of the AAUAAA in the present report as it is consistent with already published data. We appreciate this comment and the reviewer's insight into the underlying technical problem. As one might expect, we have tried to use shRNAs to 'knockdown' aCP2 from MEL/tTA cells. Although the knock-down is effective in substantially decreasing the level of aCP2 mRNA and protein in the cells, our preliminary results indicate that this results in only a two-fold increase of the level of unprocessed α-globin transcripts when compared with a scrambled shRNA control. While this effect may be significant, it is substantially less robust than the response that we observe subsequent to mutation of the C-rich αCP binding site. While there are multiple possible explanations for this difference, we would agree with the reviewer that it most likely reflects a substantial functional redundancy among the multiple aCP paralogs. We have previously shown that αCP1 and αCP2 share binding specificity and all can bind to α-globin 3'UTR (Makeyev AV, Liebhaber SA (2002) The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 8: 265-278), thus rendering the 'knockdown' approach problematic. It is for this reason that we have favored focusing on the complementary approaches involving the direct inactivation of the C-rich αCP binding site (Figs. 4 and  5 ) and by supplementation of the processing reaction with recombinant αCP (Fig. 5) . These approaches, reported in our manuscript, support a role for the αCP complex as an enhancer of 3' processing.
Referee #2 (Remarks to the Author)
" I had indicated that the time course experiment shown in the original Figure 1D  was (e.g., Couttet and Grange, NAR, 2004) . It is difficult to reconcile these different kinetic and I'm not convinced that the in vivo evidence to support a defect in processing is sufficiently strong."
We appreciate the comment of the reviewer and apologize that we have not made our point sufficiently clear. In our prior response, we stated that the most dramatic and robust enrichment of the unprocessed α-globin transcripts (specifically detected by amplification with primers a/c) was observed in the comparison of the αWT and αNeut transcripts at the "time 0' (see Figure 1D ). Since this time point precedes the chase, this enrichment most likely represents an increased steady-state level of unprocessed α-globin transcripts. We detect diminishing levels of the unprocessed transcripts at subsequent time points as the unprocessed transcripts are being cleared from the nucleus during the transcriptional chase. Thus we observe low levels of transcripts that have not yet undergone 3' processing at 2 hours into the chase for the αNeut and when we overexpose our gels we can also visualize unprocessed signals from WT (and CS) constructs as well. The fact that these 3' unprocessed transcripts subsequently decrease to undetectable levels towards the end of the chase period suggests that the tet-controlled transcriptional repression is efficient in all cases. We further note that the unprocessed transcripts that we detect by the amplification between the a and c primers have already undergone splicing (note that the a+c primer set spans intron II). This serves as further support for our interpretation that the unprocessed transcripts have a specific defect in 3' processing.
In further response to this reviewer's comments, we have reread the Couttet and Grange, NAR, 2004 paper cited in his/her comment. We do not see any conflict between our data and the data in that paper. The authors of that paper use a similar tet-off system to follow β-globin mRNA decay in transfected cells (the focus of their paper is on the mechanism of decay in NMD and the potential role of accelerated polyA shortening in this pathway). They pulse cells for 3 hours with β-globin transcripts (our α-globin transcription pulse is 4 hours) and then follow the kinetics of polyA shortening of the cytoplasmic mRNA over the ensuing chase period. They find that the polyA tail of the WT β-globin mRNA was shortened at a rate of 15A's/hour over a 6 hour chase period while the NMD-sensitive β39 transcript was shortened at a faster rate (30A's/ hour). It is important to note that their assay was not designed to monitor the efficiency of the initial nuclear 3' cleavage and polyadenylation reactions nor do they detect such mRNA precursors. One would certainly expect that at their t = 0 time point unprocessed transcripts would have been present in the cell if the assay were suited for such detection.
"I had commented that most quantification assays were performed by RT-PCR and recommended We appreciate the comment from this reviewer regarding the possibility of using real-time RT-PCR analysis in our study. We have extensive experience with a broad spectrum of mRNA analyses (including real-time) and we try to use the approach that we find to be most informative and reliable in each particular setting. Although qRT-PCR is certainly an option in many settings and could be applied in the current study, we have chosen to use the a RT/PCR amplification approach because this approach allows us to directly visualize the size of the amplified products in a manner that confirms their structure and excludes any interference by the amplification of residual contaminant DNA and unspliced pre-RNA by spanning the primer over intron II (see also below). While qRT-PCR is certainly a useful approach, more 'traditional' methodologies such as northern blot, RPA, semi-quantitative RT-PCR approaches are still in frequent use and often serve as a confirmation for real-time analyses. Figure 1D (see above), it is indeed worrisome that the critical signal supporting a difference of processing in vivo is observed comparing different gels, possibly exposed for different times, using PCR products of different sequence! This situation is far from being convincing and probably do not meet the technical quality standards required for publication."
"Going back to
We apologize that in the original version of Fig. 1D we showed only the relevant segments of our analytic gels. This appears to have given the reviewer concern regarding the reliability of the studies. These data were in fact all generated in parallel and the critical comparison of the αWT and αNeut transcripts was on a single gel while the gel analyzing the αCS transcripts run in parallel. All gels were exposed and analyzed in a parallel and consistent manner. We have now revised Fig. 1D to include the full gel picture to further document this study. We have also performed the real-time PCR assay on this study as requested by this reviewer. The results are displayed in the revised manuscript as Supplemental Fig 1. The conclusion from real-time PCR assay are fully consistent with our RT/PCR assay in Figure 1D and confirms that 3'UTR C-rich region of human α-globin transcripts plays a critical role in the 3' end processing step. Disruption of this important element severely affects the generation of mature mRNA. Finally, our data (unpublished) clearly indicated that the Neut mutation does not affect
